A rare condition involving persistent visual disturbances continuing long after hallucinogen use has stopped, sometimes for months or years.
Medically reviewed by
Dr. Mihaela G.
Hallucinogen Persisting Perception Disorder (HPPD) describes the persistent or recurrent reexperiencing of perceptual disturbances similar to those experienced during hallucinogen intoxication, continuing long after the substance itself has been completely cleared from the body, sometimes for months, occasionally for years. This is genuinely different from a “flashback” in the way the term is often loosely used; HPPD describes a continuous or recurring perceptual change, not a sudden, brief return of an intoxication-like episode.
The visual disturbances most commonly described include visual snow (a persistent, static-like graininess across the visual field), halos around objects, trails following moving objects, and afterimages that persist longer than typical. Critically, people with HPPD generally retain full awareness that these perceptions aren’t real or externally caused, distinguishing this clearly from a psychotic disorder, even though the actual visual experience can be persistent and, for some, genuinely distressing.
HPPD remains a genuinely under-researched condition, and its rarity, combined with limited awareness even among clinicians, means people experiencing it sometimes struggle to find providers familiar with the condition, or to feel confident that what they’re experiencing is real and recognized rather than something to be dismissed or doubted.
Visual snow
A persistent, grainy, static-like visual disturbance across the visual field, often described as similar to television static, present continuously rather than coming and going.
Halos and trails
Halos around lights or objects, and trailing (a smeared visual trail following moving objects), often most noticeable in low light or against contrasting backgrounds.
Afterimages
Afterimages that persist longer than would be typical, sometimes appearing in inverted colors, following a visual stimulus.
Geometric patterns and other distortions
Some people report geometric patterns, micropsia or macropsia (objects appearing smaller or larger than they are), or other persistent perceptual distortions resembling milder versions of intoxication-era effects.
Preserved reality testing
A defining, clinically essential feature is that the person retains full awareness these perceptions aren’t real, distinguishing HPPD clearly from psychosis, even when the perceptual disturbance itself is persistent and distressing.
⋅ Significant distress connected to the persistent, unwanted perceptual changes
⋅ Anxiety, sometimes intensifying as a person becomes more attentive to the symptoms
⋅ Frustration connected to limited awareness or understanding of the condition, even among providers
⋅ Concern about whether the symptoms might be permanent
⋅ Persistent awareness that the visual disturbances aren’t real or externally caused
⋅ Heightened attention to visual symptoms that can itself intensify subjective distress
⋅ Difficulty concentrating, particularly when visual disturbances are prominent
⋅ Worry or rumination about the underlying cause or future course
⋅ Visual snow, a persistent grainy or static-like visual disturbance
⋅ Halos around lights and trailing after moving objects
⋅ Prolonged afterimages, sometimes in inverted colors
⋅ No additional physical symptoms beyond the visual disturbance itself in most cases
⋅ Avoidance of specific lighting conditions or visual environments that worsen symptoms
⋅ Significant focus or rumination on the visual disturbances
⋅ Seeking reassurance or repeated evaluation due to distress or uncertainty about the condition
⋅ Reduced engagement in activities affected by the visual symptoms, such as driving at night
HPPD is genuinely rare, and precise prevalence figures remain uncertain given inconsistencies in reporting, diagnostic criteria application, and likely underrecognition, but it’s considerably less common than the more transient, brief “flashback” experiences some hallucinogen users report.
Risk factors include more frequent or higher-dose hallucinogen use, though HPPD has also been reported following limited use, including, rarely, a single exposure, suggesting individual vulnerability plays a meaningful role beyond simply cumulative exposure. A personal history of anxiety appears to be a relevant risk factor, both for developing the condition and for the degree of distress connected to it.
Comorbidity with anxiety disorders is notable and clinically significant, since anxiety can both contribute to the condition’s development and significantly intensify the subjective distress connected to ongoing symptoms, creating a pattern where attention to and worry about the visual disturbances may worsen the overall experience.
The underlying mechanism of HPPD remains incompletely understood, reflecting how genuinely under-researched this rare condition is, though several plausible explanations have been proposed.
Lasting changes in visual cortex processing are suspected to underlie the condition, potentially reflecting persistent alterations in inhibitory neural circuits involved in visual processing following hallucinogen exposure, though the precise mechanism remains an active area of limited but ongoing research.
Individual vulnerability appears to matter considerably, given that HPPD has been reported following relatively limited hallucinogen use in some individuals, while others with considerably more extensive use never develop the condition, suggesting some people may have an underlying predisposition, whether genetic, neurological, or psychological, that increases susceptibility.
Anxiety’s role in symptom maintenance and intensity is increasingly recognized as clinically important, even if not necessarily the root cause; heightened attention to and worry about the visual disturbances can create a cycle where anxiety intensifies subjective awareness and distress connected to symptoms that might otherwise be more easily ignored or tolerated.
HPPD is diagnosed when there is persistent or recurrent reexperiencing, following cessation of hallucinogen use, of perceptual symptoms similar to those experienced during intoxication, such as geometric hallucinations, false perceptions of movement in peripheral visual fields, flashes of color, intensified colors, trailing images, perceptions of entire objects, afterimages, and halos around objects. The symptoms cause clinically significant distress or impairment, and the person maintains intact reality testing, recognizing that these perceptions don’t reflect external reality. Symptoms aren’t attributable to another medical condition (such as certain neurological or ophthalmological conditions) and aren’t better explained by another mental disorder.
Differential diagnosis is genuinely important given symptom overlap with several other conditions. Visual snow syndrome, which can occur independently of any hallucinogen exposure, should be considered, particularly when there’s no clear history of hallucinogen use. Migraine with aura, certain ophthalmological conditions, and other neurological conditions affecting visual processing should be ruled out through appropriate evaluation, given that visual disturbances have many possible causes beyond hallucinogen exposure specifically.
Treatment for HPPD is limited by the condition’s rarity and correspondingly thin research base, though some approaches have shown reasonable, if not extensively validated, promise.
Addressing anxiety directly
Given how significantly anxiety can intensify subjective distress and attention to symptoms, addressing this directly through therapy, particularly approaches that reduce hypervigilance and excessive monitoring of the visual disturbances, is often a genuinely helpful component of treatment, even when it doesn’t eliminate the underlying visual symptoms themselves.
Certain medications
Some medications, including certain anticonvulsants and benzodiazepines, have been reported, in limited case studies, to provide some symptom relief for select individuals, though the evidence base remains thin, and treatment is generally approached on an individualized basis given the lack of large, controlled trials specific to this condition.
Psychoeducation and validation
Given how underrecognized this condition is, simply receiving an accurate diagnosis and understanding that the experience is real, recognized, and not a sign of psychosis can itself meaningfully ease the distress connected to feeling dismissed or doubted.
Avoiding further hallucinogen use
Given the uncertain relationship between continued use and symptom progression, avoiding further hallucinogen exposure is generally a reasonable, cautious recommendation for anyone diagnosed with this condition.
Seek a clinician who takes the condition seriously and is willing to learn about it if not already familiar. Given how underrecognized HPPD is, finding genuinely informed, validating care can be a meaningful part of managing the distress connected to this condition.
Work on reducing hypervigilant attention to the visual symptoms where possible. Since heightened focus and anxiety can intensify subjective distress, approaches that help redirect attention, alongside addressing any underlying anxiety, can ease the overall experience even without eliminating the visual disturbance itself.
Avoid further hallucinogen use. Given the uncertain relationship between continued exposure and symptom course, this is a reasonable, cautious step for anyone experiencing this condition.
Connect with others who understand this specific experience, if possible. Given the condition’s rarity and limited general awareness, finding peer support or accurate information can ease the isolation some people feel when navigating an unusual, underrecognized condition.
Be patient with the diagnostic and treatment process. Given the limited research base, finding an approach that helps may take some individualized trial and adjustment, working closely with a clinician open to this process.
The outlook for HPPD is genuinely variable, and reliable, large-scale data on long-term course is limited given the condition’s rarity.
Some people experience gradual improvement over time, even without specific treatment, while for others, symptoms can persist for an extended period, sometimes years, though even in these cases, the distress connected to the condition can often be meaningfully eased through addressing anxiety and developing strategies for reduced symptom-focused attention, even when the underlying visual disturbance itself doesn’t fully resolve.
Accurate diagnosis and validation appear to matter considerably for overall wellbeing, given how much distress can stem not just from the visual symptoms themselves, but from feeling dismissed, doubted, or unable to find informed care.
Seek evaluation if you’re experiencing persistent visual disturbances, visual snow, halos, trailing, or prolonged afterimages, that have continued well beyond any period of recent hallucinogen use.
Seek a thorough evaluation to rule out other potential causes, including neurological or ophthalmological conditions, given the symptom overlap with several other possible explanations for persistent visual disturbance.
Seek support for any accompanying anxiety directly, given how significantly this can intensify the distress connected to the condition, even when it isn’t necessarily the root cause of the visual symptoms themselves.
Someone in your life might be quietly looking for this. Share it:
These conditions share overlapping symptoms and are often misdiagnosed.
Not exactly, and this distinction matters. The term “flashback” is often used loosely to describe a brief, sudden return of intoxication-like effects, but HPPD specifically refers to a persistent or recurring perceptual disturbance that continues, sometimes continuously, well beyond any period of recent use. This is a meaningfully different, generally more sustained experience than a brief, occasional flashback, and reflects a distinct, formally recognized diagnostic category.
No, and this is a clinically important distinction. A defining feature of HPPD is that the person retains full awareness that the visual disturbances aren’t real or externally caused, distinguishing it clearly from psychosis, where this awareness, or reality testing, is impaired. People with HPPD know they’re experiencing a perceptual disturbance, even though the experience itself can be persistent and distressing.
It’s genuinely rare, and precise prevalence figures remain uncertain given inconsistent reporting and diagnostic application, but it’s considerably less common than the more transient, brief flashback experiences some hallucinogen users report. This rarity, combined with limited research and awareness, means many clinicians have limited familiarity with the condition, which can make finding informed care more challenging than it should be.
This varies considerably between individuals. Some people experience gradual improvement over time, even without specific treatment, while for others, symptoms can persist for an extended period. Even when the underlying visual disturbance doesn’t fully resolve, addressing any accompanying anxiety and reducing hypervigilant attention to the symptoms can often meaningfully ease the overall distress connected to the condition.
Halpern, J. H., & Pope, H. G. (2003). Hallucinogen persisting perception disorder: what do we know after 50 years? Drug and Alcohol Dependence, 69(2), 109–119. PubMed
Halpern, J. H., Lerner, A. G., & Passie, T. (2018). A review of hallucinogen persisting perception disorder (HPPD) and an exploratory study of subjects claiming symptoms of HPPD. Current Topics in Behavioral Neurosciences, 36, 333–360. PubMed
Martinotti, G., Santacroce, R., Pettorruso, M., Montemitro, C., Spano, M. C., Lorusso, M., di Giannantonio, M., & Lerner, A. G. (2018). Hallucinogen persisting perception disorder: etiology, clinical features, and therapeutic perspectives. Brain Sciences, 8(3), 47. PubMed
Lerner, A. G., Rudinski, D., Bor, O., & Goodman, C. (2014). Flashbacks and HPPD: a clinical-oriented concise review. Israel Journal of Psychiatry and Related Sciences, 51(4), 296–301. PubMed
Puledda, F., Schankin, C., & Goadsby, P. J. (2020). Visual snow syndrome: a clinical and phenotypical description of 1,100 cases. Neurology, 94(6), e564–e574. PubMed
